- ICH GCP
- 미국 임상 시험 레지스트리
- Search trials
Clinical Trials on 원발성 전신성 혈관염 in Korea, Republic of
총 13290 건
-
Seoul National University Hospital알려지지 않은
-
Asan Medical CenterSamsung Medical Center; Seoul National University Hospital; Kyunghee University Medical Center알려지지 않은
-
Hanyang University Seoul HospitalMinistry of Health & Welfare, Korea; Corestem, Inc.모병
-
Anterogen Co., Ltd.종료됨
-
Korean Gynecologic Oncology Group알려지지 않은난소 암 | 나팔관암 | 원발성 복막암대한민국
-
Samsung Medical CenterSK Chemicals Co., Ltd.빼는
-
Samsung Medical CenterNational Research Foundation of Korea알려지지 않은
-
Samsung Medical CenterNational Research Foundation of Korea; Sungkyunkwan University알려지지 않은
-
Yonsei University완전한Primary Family Caregivers of ICU Patients대한민국
-
Allergan완전한
-
Seoul National University Hospital완전한
-
Samsung Medical Center모병
-
Seoul National University Hospital완전한
-
Taejoon Pharmaceutical Co., Ltd.완전한안구 고혈압 | 원발성 개방각 녹내장대한민국
-
Kim, Seok JinCelltrion; Samyang Biopharmaceuticals Corporation모병
-
Seoul National University Hospital완전한
-
Seoul National University Hospital완전한
-
Seoul National University HospitalColoplast A/S초대로 등록
-
Sahmyook University완전한
-
Seoul National University Hospital완전한
-
Seoul National University HospitalKyung Hee University Hospital at Gangdong완전한
-
Samsung Medical Center모집하지 않고 적극적으로
-
Institut de Recherches Internationales Servier종료됨
-
Yonsei UniversityCanariaBio Inc.모병PARP 억제제 내성 난소암, 나팔관암 또는 원발성 복막암 환자는 백금 재치료 대상이 아닙니다.대한민국
-
Yonsei University모병
-
Yuhan Corporation완전한
-
Chong Kun Dang Pharmaceutical모병
-
Hanmi Pharmaceutical Company Limited완전한